A Multifaceted Evaluation of National Off-label Neurology Applications


Yurtogullari S., Rahmanlar H., Alkan A., Bayar B., Gursoz H., UZUN ADATEPE N.

TURKISH JOURNAL OF NEUROLOGY, cilt.26, sa.3, ss.235-241, 2020 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 3
  • Basım Tarihi: 2020
  • Doi Numarası: 10.4274/tnd.2020.37791
  • Dergi Adı: TURKISH JOURNAL OF NEUROLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.235-241
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Objective: Off-label drug use (OLDU) of neurologic diseases is approved by a regulatory authority, the Turkish Medicines and Medical Devices Agency (TMMDA) in Turkey. It was aimed to investigate the most common neurologic drugs relevant to off-label prescribing and the most prescribed diagnosis, demographic and medical characteristics of patients with OLDU applications in Turkey.